Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable (II)-65-1 (IGHVII-65-1) is a pseudogene in the human immunoglobulin heavy chain variable region locus. Pseudogenes are non-functional derivatives of genes that have lost their protein-coding ability or are otherwise defective—they are not transcribed into functional proteins and therefore do not contribute directly to immune responses or therapeutic targeting. IGHVII-65-1 is listed as a pseudogene in genetic databases and does not encode an active part of the immunoglobulin (antibody) protein family, which are critical to adaptive immunity for recognizing diverse antigens[2][3][8]. This gene is not a therapeutic target since it is a pseudogene and does not produce a functional protein[2][3]. There are no known drugs, disease associations, or biomarker roles linked with this gene; it is significant mainly for genetic and evolutionary studies of the immunoglobulin gene family[8]. The locus is located in the human IGH cluster on chromosome 14q32.33[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable (II)-65-1 (IGHVII-65-1).